427 related articles for article (PubMed ID: 18434641)
1. The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome.
Nectoux J; Bahi-Buisson N; Guellec I; Coste J; De Roux N; Rosas H; Tardieu M; Chelly J; Bienvenu T
Neurology; 2008 May; 70(22 Pt 2):2145-51. PubMed ID: 18434641
[TBL] [Abstract][Full Text] [Related]
2. Epilepsy in Rett syndrome---the experience of a National Rett Center.
Nissenkorn A; Gak E; Vecsler M; Reznik H; Menascu S; Ben Zeev B
Epilepsia; 2010 Jul; 51(7):1252-8. PubMed ID: 20491871
[TBL] [Abstract][Full Text] [Related]
3. Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome.
Buoni S; Zannolli R; Felice CD; Saponari S; Strambi M; Dotti MT; Castrucci E; Corbini L; Orsi A; Hayek J
Clin Neurophysiol; 2008 Nov; 119(11):2455-8. PubMed ID: 18842453
[TBL] [Abstract][Full Text] [Related]
4. MECP2 mutations in Serbian Rett syndrome patients.
Djarmati A; Dobricić V; Kecmanović M; Marsh P; Jancić-Stefanović J; Klein C; Djurić M; Romac S
Acta Neurol Scand; 2007 Dec; 116(6):413-9. PubMed ID: 17986102
[TBL] [Abstract][Full Text] [Related]
5. The ups and downs of BDNF in Rett syndrome.
Sun YE; Wu H
Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
[TBL] [Abstract][Full Text] [Related]
6. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
[TBL] [Abstract][Full Text] [Related]
7. X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype.
Xinhua Bao ; Shengling Jiang ; Fuying Song ; Hong Pan ; Meirong Li ; Wu XR
J Child Neurol; 2008 Jan; 23(1):22-5. PubMed ID: 18184939
[TBL] [Abstract][Full Text] [Related]
8. The Val66Met polymorphism in the BDNF gene is associated with epilepsy in fragile X syndrome.
Louhivuori V; Arvio M; Soronen P; Oksanen V; Paunio T; Castrén ML
Epilepsy Res; 2009 Jul; 85(1):114-7. PubMed ID: 19394799
[TBL] [Abstract][Full Text] [Related]
9. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy.
Agosti C; Borroni B; Archetti S; Akkawi NM; Padovani A
Neurosci Lett; 2008 Oct; 443(3):228-31. PubMed ID: 18692116
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
11. Influence of mutation type and location on phenotype in 123 patients with Rett syndrome.
Huppke P; Held M; Hanefeld F; Engel W; Laccone F
Neuropediatrics; 2002 Apr; 33(2):63-8. PubMed ID: 12075485
[TBL] [Abstract][Full Text] [Related]
12. Large genomic rearrangements in MECP2.
Ravn K; Nielsen JB; Skjeldal OH; Kerr A; Hulten M; Schwartz M
Hum Mutat; 2005 Mar; 25(3):324. PubMed ID: 15712379
[TBL] [Abstract][Full Text] [Related]
13. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
14. Social impairments in Rett syndrome: characteristics and relationship with clinical severity.
Kaufmann WE; Tierney E; Rohde CA; Suarez-Pedraza MC; Clarke MA; Salorio CF; Bibat G; Bukelis I; Naram D; Lanham DC; Naidu S
J Intellect Disabil Res; 2012 Mar; 56(3):233-47. PubMed ID: 21385260
[TBL] [Abstract][Full Text] [Related]
15. Rett syndrome: from the gene to the disease.
Matijevic T; Knezevic J; Slavica M; Pavelic J
Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
[TBL] [Abstract][Full Text] [Related]
16. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes.
Amir RE; Van den Veyver IB; Schultz R; Malicki DM; Tran CQ; Dahle EJ; Philippi A; Timar L; Percy AK; Motil KJ; Lichtarge O; Smith EO; Glaze DG; Zoghbi HY
Ann Neurol; 2000 May; 47(5):670-9. PubMed ID: 10805343
[TBL] [Abstract][Full Text] [Related]
17. Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene.
Bartholdi D; Klein A; Weissert M; Koenig N; Baumer A; Boltshauser E; Schinzel A; Berger W; Mátyás G
Clin Genet; 2006 Apr; 69(4):319-26. PubMed ID: 16630165
[TBL] [Abstract][Full Text] [Related]
18. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.
Hwang JP; Tsai SJ; Hong CJ; Yang CH; Lirng JF; Yang YM
Neurobiol Aging; 2006 Dec; 27(12):1834-7. PubMed ID: 16343697
[TBL] [Abstract][Full Text] [Related]
19. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
20. Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations.
Temudo T; Oliveira P; Santos M; Dias K; Vieira J; Moreira A; Calado E; Carrilho I; Oliveira G; Levy A; Barbot C; Fonseca M; Cabral A; Dias A; Cabral P; Monteiro J; Borges L; Gomes R; Barbosa C; Mira G; Eusébio F; Santos M; Sequeiros J; Maciel P
Neurology; 2007 Apr; 68(15):1183-7. PubMed ID: 17420401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
